We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Bimodal Contrast Agent Advances Medical Imaging

By MedImaging International staff writers
Posted on 19 Aug 2019
Print article
A new study details a two-in-one probe made of a contrast agent for magnetic resonance imaging (MRI) and a dye for photoacoustic imaging (PI).

Developed at the University of Mons (Belgium) and the Center of Microscopy and Molecular Imaging (CMMI; Charleroi, Belgium), the bimodal agent combines the MRI gadolinium agent Gd-PCTA, and an organic fluorophore dye called ZW800-1. A L‐lysine derivative joins the two via conventional protein end connections. The L‐lysine derivative also possesses a third connectivity, which can be of used to add another biovector, such as a peptide that specifically recognizes a biological disorder. This could make the bimodal probe trimodal.

The bimodal probe enhances MRI contrast as strongly as a commercial MRI agent, while at the same time providing a photoacoustic signal similar to the original PAI probe. The probe can thus provide hybrid images with a high anatomical resolution provided by MRI, and precise localization of the contrast agent thanks to PAI. Preliminary relaxometric and photoacoustic characterizations indicate that the bimodal agent fulfills its function. The study was published on June 26, 2019, in the European Journal of Inorganic Chemistry.

“The aim is to improve the image by combining photoacoustic imaging and magnetic resonance imaging by using a bimodal probe,” said Professor Sophie Laurent, PhD, of the University of Mons. “The organic dye enables PAI, thanks to its fluorescence in the near infrared (NIRF), and the gadolinium complex based on PCTA is ideal for MRI with radio-frequency pulses. The combination leads to a precisely localized, high-resolution bimodal image.”

Related Links:
University of Mons
Center of Microscopy and Molecular Imaging

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
MRI System
uMR 588
Dose Calibration Electrometer
PC Electrometer
New
DR Flat Panel Detector
1500L

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.